United Capital Financial Advisers LLC decreased its position in DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 5.9% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 22,005 shares of the medical instruments supplier’s stock after selling 1,390 shares during the period. United Capital Financial Advisers LLC’s holdings in DENTSPLY SIRONA were worth $1,284,000 at the end of the most recent reporting period.
Other institutional investors have also recently bought and sold shares of the company. Greenwood Capital Associates LLC bought a new position in shares of DENTSPLY SIRONA during the 2nd quarter valued at $215,000. APG Asset Management N.V. acquired a new stake in shares of DENTSPLY SIRONA during the 2nd quarter valued at about $1,599,000. Captrust Financial Advisors boosted its position in shares of DENTSPLY SIRONA by 31.3% during the 2nd quarter. Captrust Financial Advisors now owns 5,833 shares of the medical instruments supplier’s stock valued at $341,000 after acquiring an additional 1,390 shares in the last quarter. Parametric Portfolio Associates LLC boosted its position in shares of DENTSPLY SIRONA by 4.9% during the 2nd quarter. Parametric Portfolio Associates LLC now owns 1,040,967 shares of the medical instruments supplier’s stock valued at $60,751,000 after acquiring an additional 48,872 shares in the last quarter. Finally, MML Investors Services LLC acquired a new stake in shares of DENTSPLY SIRONA during the 2nd quarter valued at about $226,000. 94.67% of the stock is owned by hedge funds and other institutional investors.
Several analysts recently issued reports on XRAY shares. Evercore ISI assumed coverage on shares of DENTSPLY SIRONA in a research report on Friday, July 26th. They issued an “in-line” rating for the company. BidaskClub cut DENTSPLY SIRONA from a “sell” rating to a “strong sell” rating in a research note on Tuesday, September 10th. HC Wainwright restated a “neutral” rating and issued a $57.00 price objective (up from $55.00) on shares of DENTSPLY SIRONA in a research note on Tuesday, July 9th. Zacks Investment Research cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating and set a $62.00 price objective on the stock. in a research note on Monday, May 27th. Finally, Barrington Research restated a “buy” rating and issued a $63.00 price objective on shares of DENTSPLY SIRONA in a research note on Monday, August 5th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and four have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $54.57.
DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Friday, August 2nd. The medical instruments supplier reported $0.66 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.62 by $0.04. DENTSPLY SIRONA had a return on equity of 9.19% and a net margin of 2.67%. The firm had revenue of $1.01 billion for the quarter, compared to analysts’ expectations of $1.04 billion. During the same period in the prior year, the business posted $0.60 earnings per share. The company’s revenue was down 3.1% on a year-over-year basis. Sell-side analysts forecast that DENTSPLY SIRONA Inc will post 2.39 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 11th. Stockholders of record on Friday, September 27th will be given a dividend of $0.10 per share. The ex-dividend date of this dividend is Thursday, September 26th. This is a boost from DENTSPLY SIRONA’s previous quarterly dividend of $0.09. This represents a $0.40 annualized dividend and a dividend yield of 0.79%. DENTSPLY SIRONA’s dividend payout ratio is currently 17.41%.
DENTSPLY SIRONA Profile
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Featured Story: Gap Down Stocks
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.